Chubb Limited (CB)
(Delayed Data from NYSE)
$288.87 USD
+0.31 (0.11%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $288.18 -0.69 (-0.24%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$288.87 USD
+0.31 (0.11%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $288.18 -0.69 (-0.24%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
CB or TKOMY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CB vs. TKOMY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Virtu Financial (VIRT) & SMTAM Unite to Improve Trading Workflow
by Zacks Equity Research
Virtu Financial (VIRT) collaborates with Sumitomo Mitsui Trust Asset Management to integrate its investment suite to improve workflows.
4 P&C Insurers to Add to Portfolio Amid a Sluggish September
by Tanuka De
Better pricing, increase in interest rate, exposure growth and solid capital position should help Axis Capital (AXS), Chubb Limited (CB), Cincinnati Financial (CINF) and First American Financial (FAF) deliver operational excellence and in turn better returns for investors.
Lincoln National (LNC) Stock Up 8.7% in 3 months: Here's Why
by Zacks Equity Research
Lincoln National's (LNC) improving net investment income and strong Group Protection business poise the company well for growth.
Here's Why You Should Retain Coinbase Global (COIN) Stock Now
by Zacks Equity Research
Coinbase Global (COIN) is expected to benefit from reduced operating expenses and an enhanced product suite in the future.
Reasons to Hold American International (AIG) Stock Right Now
by Zacks Equity Research
Streamlining of operations, improving premiums and increasing rates poise American International (AIG) well for growth.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Companies Committed to Boosting Shareholder Value
by Derek Lewis
All three of these companies have shown a commitment to shareholders, whether that be through share buybacks or dividend hikes. Is it time to buy?
CB vs. TKOMY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CB vs. TKOMY: Which Stock Is the Better Value Option?
Here's Why Investors Should Retain Hartford Financial (HIG)
by Zacks Equity Research
Hartford Financial (HIG) remains well-poised for growth on the back of strength in its Commercial Lines and Group Benefits businesses. A strong financial position enables business investments.
Kinsale Capital Group, Inc. (KNSL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Kinsale Capital Group, Inc. (KNSL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Investors May Consider Betting on Chubb (CB) Now
by Zacks Equity Research
Chubb (CB) stands to gain from new business and strong renewal retention, acquisitions, higher reinvestment rates and effective capital deployment.
Zacks Investment Ideas feature highlights: Arch Capital, NetEase and Chubb
by Zacks Equity Research
Arch Capital, NetEase and Chubb are part of the Zacks Investment Ideas article.
Buy These 3 Low-Beta Stocks to Navigate Volatility
by Derek Lewis
With volatility creeping back into the market, blending a layer of defense into portfolios could be highly beneficial. And these three low-beta stocks provide precisely that.
Why Is Chubb (CB) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights Merck, Philip Morris, Qualcomm, CVS Health and Chubb
by Zacks Equity Research
Merck, Philip Morris, Qualcomm, CVS Health and Chubb are included in this Analyst Blog.
Top Stock Reports for Merck, Philip Morris & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Philip Morris International Inc. (PM) and QUALCOMM Incorporated (QCOM).
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
CB or TKOMY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CB vs. TKOMY: Which Stock Is the Better Value Option?
Hartford Financial (HIG) Q2 Earnings Beat on Commercial Lines Unit
by Zacks Equity Research
Hartford Financial's (HIG) Q2 results reflect growing premiums in the Group Benefits business and improved net investment income across Hartford Funds unit, partly offset by higher catastrophe losses.
Chubb's (CB) Q2 Earnings Top Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Chubb's (CB) Q2 results reflect higher premium revenue growth across all the segments, partly offset by higher catastrophe loss.
Chubb (CB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Chubb (CB) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Chubb (CB) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 11.56% and 4.94%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?